[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f9cykFMbck3R8_VlHWzGybKpQc3mu2fC-oIO-_0ISn8M":3},{"_id":4,"category":5,"content":9,"date":10,"heroImage":9,"newsPageBuilder":11,"seo":9,"slug":59,"title":60},"4f34aa77-5901-4e2e-8bb7-5d24cb7279b5",{"_id":6,"slug":7,"title":8},"d5f23208-d5ad-4b48-a510-a5616e101bb2","general","General",null,"2022-01-12T00:00:00.000Z",[12],{"_key":13,"_type":14,"content":15},"nc16","newsContent",[16,27,35,43,51],{"_key":17,"_type":18,"children":19,"markDefs":25,"style":26},"b16p1","block",[20],{"_key":21,"_type":22,"marks":23,"text":24},"s16p1","span",[],"KLISBio (Silk Biomaterials S.r.l.) has named Rodrigo Bianchi to the position of Chairman, taking over responsibilities from founder Antonio Alessandrino. The appointment became effective December 20, 2021.",[],"normal",{"_key":28,"_type":18,"children":29,"markDefs":34,"style":26},"b16p2",[30],{"_key":31,"_type":22,"marks":32,"text":33},"s16p2",[],"Bianchi brings three decades of healthcare leadership experience. His recent role was President of International Markets at Smith & Nephew, following 26 years at Johnson & Johnson, where he led divisions including DePuy Mitek and Ethicon. His career began at Procter & Gamble Italy.",[],{"_key":36,"_type":18,"children":37,"markDefs":42,"style":26},"b16p3",[38],{"_key":39,"_type":22,"marks":40,"text":41},"s16p3",[],"Bianchi commented: \"The role KLISBio is positioned to play in the future of health innovation is unparalleled. I'm honored to serve as Chairman\" for this regenerative medicine company.",[],{"_key":44,"_type":18,"children":45,"markDefs":50,"style":26},"b16p4",[46],{"_key":47,"_type":22,"marks":48,"text":49},"s16p4",[],"KLISBio develops silk-based biomedical solutions targeting clinical needs including peripheral nerve injuries, vascular diseases, bone defects, and tendon repairs. The company's first product, a silk-based nerve repair graft, is expected to reach clinical availability in 2023.",[],{"_key":52,"_type":18,"children":53,"markDefs":58,"style":26},"b16p5",[54],{"_key":55,"_type":22,"marks":56,"text":57},"s16p5",[],"Alessandrino transitions to Chief Technology Officer while remaining on the board. CEO Gabriele Grecchi noted that Rodrigo bringing additional insights and ideas will guide KLISBio's growth phase.",[],"klisbio-new-chairman","KLISBio appoints Rodrigo Bianchi as new Chairman of the Board"]